GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
March 06, 2024 09:00 ET | GeoVax, Inc.
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7
May 22, 2018 09:00 ET | GeoVax, Inc.
CEO Robert McNally to Speak as part of BIO’s One Health Day Program ATLANTA, GA., May 22, 2018 (GLOBE NEWSWIRE) --  GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...